Soleno Therapeutics Inc
SLNO
Revenue
1.00k
▼-264.00k▼-99.62%
3 Months ChangeAssets
304.13M
▲135.29M▲80.13%
3 Months ChangeLiabilities
23.37M
▼-2.08M▼-8.16%
3 Months ChangeFree Cash Flow
-12.54M
▼-5.81M▼-86.37%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-15
Form 8-K
ID: 0001193125-24-201313
2024-08-07
Form 8-K
ID: 0001193125-24-196040
2024-08-07
Form 10-Q
ID: 0000950170-24-092713
2024-07-19
Form 8-K
ID: 0001193125-24-181717
2024-07-19
Form 8-K
ID: 0001193125-24-181329
2024-06-28
Form 8-K
ID: 0001193125-24-172238
2024-06-20
Form 8-K
ID: 0001193125-24-164463
2024-06-06
Form 8-K
ID: 0001193125-24-156113
2024-05-10
Form 8-K
ID: 0001193125-24-135478
2024-05-09
Form 10-Q
ID: 0000950170-24-057109